CLARIFICATION: California Judge Dismisses Affy Claims Against Incyte | GenomeWeb

This update serves to clarify that Affymetrix does not make cDNA arrays, as we erroneously reported on Monday. Incyte manufactures such arrays. Affy makes synthesized arrays for oligonucleotides that allow scientists to manufacture their own cDNA arrays.

NEW YORK, Oct. 15 – A US District Court has dismissed two claims filed by Affymetrix which asserted that Incyte had violated its “two-color” patent while also denying Incyte’s motion to find another Affymetrix patent invalid, the companies said on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.